|
Index of reports
> Death (164)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Copegus (Ribavirin) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 164 Next >>
Possible Copegus side effects in male
Reported by a physician from France on 2012-08-24
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Pancreatitis Acute, Pancreatic Necrosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-27
End date: 2012-01-23
Dedrogyl
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-27
End date: 2011-12-08
Incivek
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-27
End date: 2012-01-23
Pegasys
Indication: Hepatitis C
Start date: 2011-10-27
End date: 2012-01-23
Other drugs received by patient: Neorecormon
Possible Copegus side effects in 49 year old male
Reported by a individual with unspecified qualification from France on 2012-08-22
Patient: 49 year old male, weighing 96.0 kg (211.2 pounds)
Reactions: Vomiting, General Physical Health Deterioration, Pyrexia, Multi-Organ Failure, Neutropenia, Asthenia, Septic Shock, Leukopenia, Infectious Peritonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2012-05-29
End date: 2012-06-06
Copegus
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2012-04-30
End date: 2012-06-06
Pegasys
Dosage: 180 ?g, qw
Indication: Hepatitis C
Start date: 2012-04-30
End date: 2012-06-06
Other drugs received by patient: Vitamin D; Aldactone; Ixel; Neupogen; Delursan; Abilify; Lasix; Revolade
Possible Copegus side effects in
Reported by a physician from Germany on 2012-08-16
Patient:
Reactions: Retinal Injury, Retinal Detachment
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-09
End date: 2012-03-23
Pegasys
Dosage: 180 ?g, qw
Indication: Hepatitis C
Start date: 2011-09-09
End date: 2012-03-23
Victrelis
Dosage: 2400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-09
End date: 2012-03-23
Possible Copegus side effects in female
Reported by a physician from Portugal on 2012-08-15
Patient: female
Reactions: Metabolic Acidosis, Peritoneal Haemorrhage, Anaemia, Hypotension, Coma, Fall, Haemothorax, Anxiety, Cardio-Respiratory Arrest, Chest Pain, Multiple Injuries, Bradycardia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Blinded BI 201335
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-28
End date: 2012-02-26
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-28
End date: 2012-02-26
Pegasys
Indication: Hepatitis C
Start date: 2011-11-28
Other drugs received by patient: Sertralina; Sertralina
Possible Copegus side effects in male
Reported by a physician from Germany on 2012-08-13
Patient: male
Reactions: Pancytopenia, Cardiac Failure Congestive
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-23
End date: 2012-06-08
Daclatasvir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-23
End date: 2012-06-08
Pegasys
Indication: Hepatitis C
Start date: 2012-02-23
End date: 2012-06-08
Other drugs received by patient: Cotrim D.s.; Reyataz; Truvada; Norvir; Metoclopramide
Possible Copegus side effects in
Reported by a physician from Germany on 2012-08-10
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Pegasys
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Possible Copegus side effects in female
Reported by a physician from Spain on 2012-08-09
Patient: female, weighing 62.2 kg (136.8 pounds)
Reactions: Multi-Organ Failure, Cellulitis, Renal Failure, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Blinded Alisporivir
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-19
End date: 2012-03-15
Copegus
Indication: Hepatitis C
Start date: 2011-07-19
End date: 2012-03-13
Pegasys
Indication: Hepatitis C
Start date: 2011-07-19
End date: 2012-03-15
Possible Copegus side effects in
Reported by a physician from Germany on 2012-08-09
Patient:
Reactions: Renal Disorder, Blood Bilirubin Abnormal, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Pegasys
Indication: Hepatitis C
Telaprevir
Indication: Hepatitis C
Possible Copegus side effects in female
Reported by a physician from Spain on 2012-08-06
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Anaemia, Pancytopenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-30
End date: 2011-04-27
Pegasys
Indication: Hepatitis C
Start date: 2011-03-30
End date: 2011-04-27
Other drugs received by patient: Prednisone
Possible Copegus side effects in 49 year old male
Reported by a physician from Germany on 2012-08-03
Patient: 49 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Hepatic Failure, Ascites, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
Pegasys
Indication: Hepatitis C
Start date: 2011-10-20
Telaprevir
Dosage: last dos prior to sae; 12/jan/2012
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
Possible Copegus side effects in
Reported by a physician from Germany on 2012-08-02
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Pegasys
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Possible Copegus side effects in male
Reported by a physician from Mexico on 2012-07-31
Patient: male, weighing 59.0 kg (129.8 pounds)
Reactions: Victim of Crime
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Indication: HIV Infection
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-16
End date: 2012-03-06
Pegasys
Indication: Hepatitis C
Start date: 2011-08-16
End date: 2012-03-06
Pegasys
Indication: HIV Infection
Other drugs received by patient: Ritonavir; Ritonavir; Truvada; Saquinavir; Saquinavir; Truvada
Possible Copegus side effects in male
Reported by a physician from Austria on 2012-07-30
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Arthropathy, Gout, Atrial Fibrillation, Myocardial Infarction, Nephropathy
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-02-05
Pegasys
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-02-05
Telaprevir
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-02-05
Other drugs received by patient: Nebivolol; Prednisolone; Fluticasone Propionate / Salmeterol; Marcumar; Urosin; Spiriva; Lasilactone; Pantoprazole Sodium; Seroquel
Possible Copegus side effects in male
Reported by a health professional (non-physician/pharmacist) from Chile on 2012-07-27
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Anaemia, Anaemia Haemolytic Autoimmune, Pyrexia, Organ Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-23
End date: 2012-07-14
Pegasys
Indication: Hepatitis C
Start date: 2012-05-23
End date: 2012-07-14
Possible Copegus side effects in male
Reported by a physician from Mexico on 2012-07-26
Patient: male
Reactions: Weight Decreased, Malaise, Gastrointestinal Haemorrhage, Pyrexia, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-01
Pegasys
Indication: Hepatitis C
End date: 2012-02-01
Other drugs received by patient: Enalapril Maleate
Possible Copegus side effects in 58 year old male
Reported by a physician from France on 2012-07-24
Patient: 58 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Cytolytic Hepatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Start date: 2012-02-01
Copegus
Indication: Hepatitis C
Start date: 2010-11-01
End date: 2011-11-01
Pegasys
Start date: 2012-02-01
Pegasys
Indication: Hepatitis C
Start date: 2010-11-01
End date: 2011-11-01
Other drugs received by patient: Biperidys; Aluminum Hydroxide and Magnesium Trisilicate
Possible Copegus side effects in
Reported by a individual with unspecified qualification from France on 2012-07-24
Patient:
Reactions: Vomiting, Nausea, Mood Altered, Diarrhoea, Underdose, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-05-15
Pegasys
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-05-15
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-12-21
End date: 2012-02-20
Victrelis
Dosage: 600 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-29
End date: 2011-12-20
Other drugs received by patient: Escitalopram; Abilify; Atarax
Possible Copegus side effects in
Reported by a individual with unspecified qualification from France on 2012-07-23
Patient:
Reactions: Dysaesthesia, Porphyria non-Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Dosage: 1000 mg, qd
Indication: Hepatitis C
Start date: 2011-05-02
End date: 2012-04-02
Pegasys
Dosage: 150 a?g, qw
Indication: Hepatitis C
Start date: 2011-05-02
End date: 2012-04-02
Victrelis
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-05-30
End date: 2012-04-02
Other drugs received by patient: Delursan; Folic Acid; Betaselen
Possible Copegus side effects in
Reported by a individual with unspecified qualification from France on 2012-07-23
Patient:
Reactions: Abdominal Pain
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1000 mg, qd
Indication: Neutropenia
Start date: 2011-05-17
Victrelis
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-06-14
Viraferonpeg
Dosage: 1 a?g/kg, qw
Indication: Anaemia
Start date: 2011-05-17
Other drugs received by patient: Neorecormon; Neupogen
Possible Copegus side effects in female
Reported by a physician from Germany on 2012-07-23
Patient: female, weighing 105.0 kg (231.0 pounds)
Reactions: Sepsis, Hepatorenal Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Boceprevir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
Citalopram
Indication: Product Used FOR Unknown Indication
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-05
Pegasys
Indication: Hepatitis C
Start date: 2012-01-05
Possible Copegus side effects in
Reported by a physician from Germany on 2012-07-20
Patient:
Reactions: Vomiting, Renal Failure, Sepsis, Urinary Tract Infection, Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1600 mg
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
PEG-Intron
Dosage: 180 micg, qw
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
Victrelis
Dosage: 3 x 800
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-19
Other drugs received by patient: Citalopram Hydrobromide; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Ramipril
Possible Copegus side effects in
Reported by a physician from France on 2012-07-19
Patient:
Reactions: Hepatic Neoplasm Malignant
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2011-05-17
End date: 2012-06-14
Victrelis
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-06-14
End date: 2012-04-26
Viraferonpeg
Dosage: 80 a?g, qw
Start date: 2011-05-17
End date: 2012-06-14
Other drugs received by patient: Acupan; Prograf; Morphine Hydrochloride; Lovenox; Ogast; Medrol; Cellcept; Insulin
Possible Copegus side effects in
Reported by a physician from France on 2012-07-19
Patient:
Reactions: Cholelithiasis, Hepatic Pain, Condition Aggravated, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: unk unk, tid
Indication: Hepatitis C
Start date: 2012-06-18
End date: 2012-07-11
Copegus
Dosage: 600 mg, bid
Indication: Hepatitis C
Start date: 2012-05-14
Pegasys
Dosage: 180 a?g, qw
Indication: Hepatitis C
Start date: 2012-05-14
Other drugs received by patient: Insulin Aspart, Biphasic Isophane [injection]; Potassium Chloride; Lasix; Quinine Sulfate; Aldactone
Possible Copegus side effects in male
Reported by a physician from Germany on 2012-07-18
Patient: male
Reactions: Pancytopenia, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-23
End date: 2012-06-08
Daclatasvir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-23
End date: 2012-06-08
Pegasys
Indication: Hepatitis C
Start date: 2012-02-23
End date: 2012-06-08
Other drugs received by patient: Norvir; Metoclopramide; Truvada; Cotrim D.s.; Reyataz
Possible Copegus side effects in
Reported by a physician from Germany on 2012-07-18
Patient:
Reactions: Haemoglobin Decreased, Disturbance in Attention
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-02-16
Copegus
Dosage: 800 mg, qd
Administration route: Oral
Peginterferon Alfa-2B
Dosage: 150 a?g, qw
Indication: Hepatitis C
Start date: 2009-02-16
Peginterferon Alfa-2B
Dosage: 80 a?g, qw
Other drugs received by patient: Invirase; Lopinavir and Ritonavir; Fluconazole; Methadon HCL TAB
Possible Copegus side effects in 49 year old male
Reported by a physician from Spain on 2012-07-18
Patient: 49 year old male
Reactions: Gastrointestinal Haemorrhage, Pancytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2009-01-19
End date: 2009-05-04
Pegasys
Indication: Hepatitis C
Start date: 2009-01-21
End date: 2009-05-04
Possible Copegus side effects in 69 year old male
Reported by a physician from Germany on 2012-07-18
Patient: 69 year old male
Reactions: Death, Anaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Start date: 2012-01-27
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-01-01
End date: 2007-12-01
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2006-01-01
End date: 2007-12-01
Peginterferon Alfa-2A
Start date: 2012-01-27
Telaprevir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-27
End date: 2012-04-13
Other drugs received by patient: Propranolol HCL; Pantoprazole; Torsemide
Possible Copegus side effects in male
Reported by a physician from Germany on 2012-07-17
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Acute Hepatic Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: date of last dose prior to sae: 20/mar/2012
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-14
Pegasys
Dosage: date of last dose prior to sae: 14/mar/2012
Indication: Hepatitis C
Start date: 2012-02-14
Telaprevir
Dosage: date of last dose prior to sae: 20/mar/2012
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-14
Other drugs received by patient: Spironolactone; Lactulose
Possible Copegus side effects in
Reported by a consumer/non-health professional from France on 2012-07-16
Patient:
Reactions: Weight Decreased, Anaemia, Viith Nerve Paralysis
Adverse event resulted in: death
Drug(s) suspected as cause:
Copegus
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-01
End date: 2012-03-06
Copegus
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-03-06
Pegasys
Dosage: 180 a?g, unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-01
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-01
Other drugs received by patient: Oxazepam; Methadon HCL TAB; Neorecormon
Possible Copegus side effects in
Reported by a individual with unspecified qualification from France on 2012-07-16
Patient:
Reactions: Vomiting, General Physical Health Deterioration, Pyrexia, Neutropenia, Asthenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2012-05-29
End date: 2012-06-06
Copegus
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2012-04-30
End date: 2012-06-06
Pegasys
Dosage: 180 a?g, qw
Indication: Hepatitis C
Start date: 2012-04-30
End date: 2012-06-06
Other drugs received by patient: Ixel; Promacta; Delursan; Abilify; Vitamin D; Neupogen; Aldactone; Lasix
Page 1 Next >>
|
